BridgeMD
New treatment option for Parkinson Disease
Official title Balance Tele-Rehab in Parkinson's Disease
ClinicalTrials.gov ID: NCT05680597
What this study is testing
- What it's testing
- This project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 to 85
You may be able to join if
- Diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia and one or more of the...
- responsive to levodopa (self-reported)
- Hoehn \& Yahr stages I-III;
- ages 55-85 years old
- ability to follow directions in order to participate in testing procedures and exercise classes
You likely can't join if
- Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly...
- medical condition that precludes exercise
- cognitive inability to participate in an exercise program, such as MoCA score less than or equal to 19, prior diagnosis of dementia or inability to...
- recurrent fallers, defined as those who fall more than 3 times a week (from patient and caregiver recollection)
- excessive use of alcohol or recreational drugs
- recent change in medication
See the full eligibility criteria
- Diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia and one or more of the following - rest tremor, rigidity, and balance problems not from visual...
- responsive to levodopa (self-reported)
- Hoehn \& Yahr stages I-III;
- ages 55-85 years old
- ability to follow directions in order to participate in testing procedures and exercise classes
- free of any medical conditions or medication that contraindicates participation in an exercise program
- willing and able to participate in rehabilitation intervention approximately 3x/week for 4 weeks while also refraining from making changes to medications (as reasonable) or to other exercise programs during the study...
- Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly affecting gait and balance (i.e., musculoskeletal disorder, vestibular...
- medical condition that precludes exercise
- cognitive inability to participate in an exercise program, such as MoCA score less than or equal to 19, prior diagnosis of dementia or inability to follow directions
- recurrent fallers, defined as those who fall more than 3 times a week (from patient and caregiver recollection)
- excessive use of alcohol or recreational drugs
- recent change in medication
- inability to stand and walk for ISAW without an assistive device.
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.